Amorphical
Manufacturing · Israel · 51-200 Employees
View Company Info for Free
Overview
Headquarters
11 Haharash St, Ness Ziona, Central Dist...Phone Number
+972 86995333Website
www.amorphical.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
2
1
1
1
1
About Amorphical
Amorphical is a pioneering biotech company specializing in the development and manufacturing of unique natural-based medicines and dietary supplements that enhance mineral absorption and balance the body's acidity levels. The company focuses on three major therapeutic segments: bone and metabolic diseases, inflammatory disorders, and oncology, utilizing its innovative nano-amorphous mineral technology. With nearly 200 patents and extensive clinical research, Amorphical aims to transform treatments for various health conditions by providing safe and effective therapies. Their products are designed for individuals seeking to improve their overall wellbeing and address specific health challenges.Explore more
Amorphical Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Amorphical your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Amorphical
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Amorphical recently announced quarterly report
Check if Amorphical has recently received funding, and reach out quickly before it becomes old news!
Check out if Amorphical is spiking on competitors!
Funding: Get notified immidiatlly once Amorphical has new funding data
Amorphical, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Amorphical launches new products
Click to see if Amorphical had a recent Job posting/layoffs
Recommended Actions
Find VP level buyers at Amorphical
Find more new buyers
Company Profile Activity
Activity Insights
Amorphical is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Amorphical is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Amorphical.
Amorphical Tech Stack
A closer look at the technologies used by Amorphical
Amorphical News & Media
Amorphical Announces Positive Final Long-Term Results from Phase 2 Crohn's Disease Trial: Results Confirm Efficacy and Show Sustained Clinical Remission
Novel Treatment Offers Non-Immunosuppressive Approach for Localized Acid Neutralization and Calcium Delivery NES ZIONA, Israel, Dec. 16, 2025 /PRNewswire/ -- Amorphical, a developer of nano-amorphous mineral-based pharmacologic agents, today announced positive final long-term follow-up...Amorphical Announces First Patient Enrolled in Phase 2 Clinical Trial of Nano-Amorphous Mineral-Based Therapy in Stage IV Pancreatic Cancer Patients
Novel Platform Aims To Normalize Tumor Acidity, Slow Disease Progression and Extend Survival NES ZIONA, Israel, Nov. 24, 2025 /PRNewswire/ -- Amorphical, developer of nano-amorphous mineral-based pharmacologic agents for health conditions, today announced that the first patient has been...Amorphical Announces Positive Interim Results from Ongoing Clinical Trial in Crohn's Disease
Novel Nano-Amorphous Mineral-Based Therapy Shows Meaningful Clinical Improvement and Remission in Patients with Moderate-to-Severe Disease NES ZIONA, Israel, Sept. 30, 2025 /PRNewswire/ -- Amorphical, developer of nano-amorphous mineral-based pharmacologic agents for health conditions,...Amorphical Appoints Eden Ben as CEO, as Company Advances Regulatory Pathway for Nano-Amorphous Mineral-Based Therapeutics
Pipeline of Disease-Modifying Therapies Targets Hypoparathyroidism, Pancreatic Cancer, osteoporotic fractures, and Crohn's Disease NES ZIONA, Israel, Sept. 2, 2025 /PRNewswire/ -- Amorphical, developer of nano-amorphous mineral-based pharmacologic agents for health conditions, announced...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Amorphical
Sign Up For FreeTo access detailed company insights
Amorphical is a pioneering biotech company specializing in the development and manufacturing of unique natural-based medicines and dietary supplements that enhance mineral absorption and balance the body's acidity levels. The company focuses on three major therapeutic segments: bone and metabolic diseases, inflammatory disorders, and oncology, util... Read More
